Year: 2001

Development of DNA Methylation Based Ovarian Cancer Specific Molecular Markers

DNA methylation, the addition of a methyl group to a cytosine residue, is an important modification of DNA molecules essential for normal human development…

Read on

Finding Serum and Urine Protein/Peptide Markers of Ovarian Cancer for Screening

The best prospect for immediately improving ovarian cancer survival will be the development of new screening and diagnostic tests…

Read on

The Role of a Novel Gene, ZIC 2, in Causing Sporadic Ovarian Cancer

Epithelial ovarian cancer (EOC) may occur in patients with a family history of breast and/or ovarian cancer, and is referred to as a hereditary case, or in patients lacking a family history, and is referred to as a sporadic case…

Read on

Dysfunctional Apoptosome Activation in Ovarian Cancer: Implications for Pathogenesis, Prognosis, and Chemoresistance

Read on

Functional Significance of Insulin Receptors in Epithelial Ovarian Cancer: Therapeutic Implications

Ovarian cancer cells grow in response to a variety of growth factors…

Read on

Characterizing Differential Gene Expression of Drug Sensitive and Resistant Ovarian Cancer

Ovarian cancer is responsible for nearly 15,000 deaths annually in the United States and is the fifth leading cause of death from cancer among women…

Read on

Novel Approaches for Early Diagnosis of Ovarian Cancer

Genetic alterations are very promising markers for molecular diagnosis and prognosis because they can precede obvious cancer and are highly specific…

Read on

The Molecular Basis of Recurrent Ovarian Cancer and Primary Peritoneal Cancer

Read on